Endothelin-1 signaling promotes fibrosis in vitro in a bronchopulmonary dysplasia model by activating the extrinsic coagulation cascade

Journal of Immunology

Volumn 186, Issue 11, 2011, Pages 6568-6575

  Kambas, Konstantinos ^a   Chrysanthopoulou, Akrivi ^a   Kourtzelis, Ioannis ^a   Skordala, Marianna ^c   Mitroulis, Ioannis ^a   Rafail, Stavros ^b   Vradelis, Stergios ^a   Sigalas, Ioannis ^c   Wu, You Qiang ^b   Speletas, Matthaios ^d   Kolios, George ^a   Ritis, Konstantinos ^a  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^d UNIVERSITY OF THESSALY   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; ENDOTHELIN 1; PROTEINASE ACTIVATED RECEPTOR 1; THROMBIN;

ARTICLE; BLOOD CLOTTING; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; EXTRINSIC COAGULATION CASCADE; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; IN VITRO STUDY; INFANT; LUNG DYSPLASIA; LUNG FIBROSIS; LUNG LAVAGE; MYOFIBROBLAST; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEUTROPHIL COUNT; NEWBORN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UPREGULATION;

BLOTTING, WESTERN; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHOPULMONARY DYSPLASIA; CELLS, CULTURED; COLON; COMPLEMENT C5A; CONNECTIVE TISSUE GROWTH FACTOR; ENDOTHELIN-1; FEMALE; FIBROSIS; GREEN FLUORESCENT PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT, NEWBORN; LUNG; MALE; MICROSCOPY, FLUORESCENCE; MYOFIBROBLASTS; RECEPTOR, PAR-1; RECEPTORS, COMPLEMENT; RESPIRATORY DISTRESS SYNDROME, NEWBORN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; THROMBIN; THROMBOPLASTIN;

EID: 79958057011     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1003756     Document Type: Article

References (45)

1. Mackman, N. 2009. The many faces of tissue factor. J. Thromb. Haemost. 7 (Suppl 1): 136-139.
2. Ritis, K., M. Doumas, D. Mastellos, A. Micheli, S. Giaglis, P. Magotti, S. Rafail, G. Kartalis, P. Sideras, and J. D. Lambris. 2006. A novel C5a receptor-tissue factor cross-talk in neutrophils links innate immunity to coagulation pathways. J. Immunol. 177: 4794-4802.
3. Maugeri, N., M. Brambilla, M. Camera, A. Carbone, E. Tremoli, M. B. Donati, G. de Gaetano, and C. Cerletti. 2006. Human polymorphonuclear leukocytes produce and express functional tissue factor upon stimulation. J. Thromb. Haemost. 4: 1323-1330.
4. Redecha, P., R. Tilley, M. Tencati, J. E. Salmon, D. Kirchhofer, N. Mackman, and G. Girardi. 2007. Tissue factor: a link between C5a and neutrophil activation in antiphospholipid antibody induced fetal injury. Blood 110: 2423-2431. (Pubitemid 47523163)
5. Rafail, S., K. Ritis, K. Schaefer, I. Kourtzelis, M. Speletas, M. Doumas, S. Giaglis, K. Kambas, S. Konstantinides, and G. Kartalis. 2008. Leptin induces the expression of functional tissue factor in human neutrophils and peripheral blood mononuclear cells through JAK2-dependent mechanisms and TNFalpha involvement. Thromb. Res. 122: 366-375.
6. Kambas, K., M. M. Markiewski, I. A. Pneumatikos, S. S. Rafail, V. Theodorou, D. Konstantonis, I. Kourtzelis, M. N. Doumas, P. Magotti, R. A. Deangelis, et al. 2008. C5a and TNF-alpha up-regulate the expression of tissue factor in intraalveolar neutrophils of patients with the acute respiratory distress syndrome. J. Immunol. 180: 7368-7375.
7. Redecha, P., C. W. Franzke, W. Ruf, N. Mackman, and G. Girardi. 2008. Neutrophil activation by the tissue factor/Factor VIIa/PAR2 axis mediates fetal death in a mouse model of antiphospholipid syndrome. J. Clin. Invest. 118: 3453-3461.
8. Kourtzelis, I., M. M. Markiewski, M. Doumas, S. Rafail, K. Kambas, I. Mitroulis, S. Panagoutsos, P. Passadakis, V. Vargemezis, P. Magotti, et al. 2010. Complement anaphylatoxin C5a contributes to hemodialysis-associated thrombosis. Blood 116: 631-639.
9. Szotowski, B., S. Antoniak, W. Poller, H. P. Schultheiss, and U. Rauch. 2005. Procoagulant soluble tissue factor is released from endothelial cells in response to inflammatory cytokines. Circ. Res. 96: 1233-1239.
10. Parry, G. C., and N. Mackman. 1995. Transcriptional regulation of tissue factor expression in human endothelial cells. Arterioscler. Thromb. Vasc. Biol. 15: 612-621.
11. Howell, D. C., N. R. Goldsack, R. P. Marshall, R. J. McAnulty, R. Starke, G. Purdy, G. J. Laurent, and R. C. Chambers. 2001. Direct thrombin inhibition reduces lung collagen, accumulation, and connective tissue growth factor mRNA levels in bleomycin-induced pulmonary fibrosis. Am. J. Pathol. 159: 1383-1395.
12. Yu, C. C., M. J. Hsu, M. L. Kuo, R. F. Chen, M. C. Chen, K. J. Bai, M. C. Yu, B. C. Chen, and C. H. Lin. 2009. Thrombin-induced connective tissue growth factor expression in human lung fibroblasts requires the ASK1/JNK/AP-1 pathway. J. Immunol. 182: 7916-7927.
13. Imokawa, S., A. Sato, H. Hayakawa, M. Kotani, T. Urano, and A. Takada. 1997. Tissue factor expression and fibrin deposition in the lungs of patients with idiopathic pulmonary fibrosis and systemic sclerosis. Am. J. Respir. Crit. Care Med. 156: 631-636.
14. Kimura, M., K. Tani, J. Miyata, K. Sato, A. Hayashi, S. Otsuka, T. Urata, and S. Sone. 2005. The significance of cathepsins, thrombin and aminopeptidase in diffuse interstitial lung diseases. J. Med. Invest. 52: 93-100.
15. Scotton, C. J., M. A. Krupiczojc, M. Königshoff, P. F. Mercer, Y. C. Lee, N. Kaminski, J. Morser, J. M. Post, T. M. Maher, A. G. Nicholson, et al. 2009. Increased local expression of coagulation factor X contributes to the fibrotic response in human and murine lung injury. J. Clin. Invest. 119: 2550-2563.
16. Wick, G., A. Backovic, E. Rabensteiner, N. Plank, C. Schwentner, and R. Sgonc. 2010. The immunology of fibrosis: innate and adaptive responses. Trends Immunol. 31: 110-119.
17. Bogatkevich, G. S., A. Ludwicka-Bradley, and R. M. Silver. 2009. Dabigatran, a direct thrombin inhibitor, demonstrates antifibrotic effects on lung fibroblasts. Arthritis Rheum. 60: 3455-3464.
18. Hinz, B., S. H. Phan, V. J. Thannickal, A. Galli, M. L. Bochaton-Piallat, and G. Gabbiani. 2007. The myofibroblast: one function, multiple origins. Am. J. Pathol. 170: 1807-1816.
19. Erickson, A. M., S. M. de la Monte, G. W. Moore, and G. M. Hutchins. 1987. The progression of morphologic changes in bronchopulmonary dysplasia. Am. J. Pathol. 127: 474-484.
20. Jaarsma, A. S., M. A. Braaksma, W. B. Geven, W. Van Oeveren, and S. B. Oetomo. 2001. Early activation of inflammation and clotting in the preterm lamb with neonatal RDS: comparison of conventional ventilation and high frequency oscillatory ventilation. Pediatr. Res. 50: 650-657.
21. Merritt, T. A., J. M. Puccia, and I. D. Stuard. 1981. Cytologic evaluation of pulmonary effluent in neonates with respiratory distress syndrome and bronchopulmonary dysplasia. Acta Cytol. 25: 631-639.
22. Ogden, B. E., S. A. Murphy, G. C. Saunders, D. Pathak, and J. D. Johnson. 1984. Neonatal lung neutrophils and elastase/proteinase inhibitor imbalance. Am. Rev. Respir. Dis. 130: 817-821.
23. Tullus, K., G. W. Noack, L. G. Burman, R. Nilsson, B. Wretlind, and A. Brauner. 1996. Elevated cytokine levels in tracheobronchial aspirate fluids from ventilator treated neonates with bronchopulmonary dysplasia. Eur. J. Pediatr. 155: 112-116.
24. Kotecha, S., L. Wilson, A. Wangoo, M. Silverman, and R. J. Shaw. 1996. Increase in interleukin (IL)-1 beta and IL-6 in bronchoalveolar lavage fluid obtained from infants with chronic lung disease of prematurity. Pediatr. Res. 40: 250-256.
25. Munshi, U. K., J. O. Niu, M. M. Siddiq, and L. A. Parton. 1997. Elevation of interleukin-8 and interleukin-6 precedes the influx of neutrophils in tracheal aspirates from preterm infants who develop bronchopulmonary dysplasia. Pediatr. Pulmonol. 24: 331-336.
26. Niu, J. O., U. K. Munshi, M. M. Siddiq, and L. A. Parton. 1998. Early increase in endothelin-1 in tracheal aspirates of preterm infants: correlation with bronchopulmonary dysplasia. J. Pediatr. 132: 965-970.
27. Hocher, B., A. Schwarz, K. A. Fagan, C. Thöne-Reineke, K. El-Hag, H. Kusserow, S. Elitok, C. Bauer, H. H. Neumayer, D. M. Rodman, and F. Theuring. 2000. Pulmonary fibrosis and chronic lung inflammation in ET-1 transgenic mice. Am. J. Respir. Cell Mol. Biol. 23: 19-26.
28. Ross, B., P. D'Orléans-Juste, and A. Giaid. 2010. Potential role of endothelin-1 in pulmonary fibrosis: from the bench to the clinic. Am. J. Respir. Cell Mol. Biol. 42: 16-20.
29. Clozel, M., and H. Salloukh. 2005. Role of endothelin in fibrosis and anti-fibrotic potential of bosentan. Ann. Med. 37: 2-12.
30. Jobe, A. H., and E. Bancalari. 2001. Bronchopulmonary dysplasia. Am. J. Respir. Crit. Care Med. 163: 1723-1729.
31. de Blic, J., F. Midulla, A. Barbato, A. Clement, I. Dab, E. Eber, C. Green, J. Grigg, S. Kotecha, G. Kurland, et al; European Respiratory Society. 2000. Bronchoalveolar lavage in children. ERS Task Force on bronchoalveolar lavage in children. Eur. Respir. J. 15: 217-231.
32. Kouroumalis, A., R. J. Nibbs, H. Aptel, K. L. Wright, G. Kolios, and S. G. Ward. 2005. The chemokines CXCL9, CXCL10, and CXCL11 differentially stimulate G alpha i-independent signaling and actin responses in human intestinal myofibroblasts. J. Immunol. 175: 5403-5411.
33. Livak, K. J., and T. D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25: 402-408.
34. Huang, M., S. Sharma, L. X. Zhu, M. P. Keane, J. Luo, L. Zhang, M. D. Burdick, Y. Q. Lin, M. Dohadwala, B. Gardner, et al. 2002. IL-7 inhibits fibroblast TGFbeta production and signaling in pulmonary fibrosis. J. Clin. Invest. 109: 931-937.
35. Toti, P., G. Buonocore, P. Tanganelli, A. M. Catella, M. L. Palmeri, R. Vatti, and T. A. Seemayer. 1997. Bronchopulmonary dysplasia of the premature baby: an immunohistochemical study. Pediatr. Pulmonol. 24: 22-28.
36. Dik, W. A., L. J. Zimmermann, B. A. Naber, D. J. Janssen, A. H. van Kaam, and M. A. Versnel. 2003. Thrombin contributes to bronchoalveolar lavage fluid mitogenicity in lung disease of the premature infant. Pediatr. Pulmonol. 35: 34-41.
37. Ricklin, D., G. Hajishengallis, K. Yang, and J. D. Lambris. 2010. Complement: a key system for immune surveillance and homeostasis. Nat. Immunol. 11: 785-797.
38. Egidy, G., L. Juillerat-Jeanneret, P. Korth, F. T. Bosman, and F. Pinet. 2000. The endothelin system in normal human colon. Am. J. Physiol. Gastrointest. Liver Physiol. 279: G211-G222.
39. Kojima, N., M. Hori, T. Murata, Y. Morizane, and H. Ozaki. 2007. Different profiles of Ca2+ responses to endothelin-1 and PDGF in liver myofibroblasts during the process of cell differentiation. Br. J. Pharmacol. 151: 816-827.
40. Gando, S. 2010. Microvascular thrombosis and multiple organ dysfunction syndrome. Crit. Care Med. 38(2 Suppl):S35-S42.
41. Allen, J. T., R. A. Knight, C. A. Bloor, and M. A. Spiteri. 1999. Enhanced insulin-like growth factor binding protein-related protein 2 (connective tissue growth factor) expression in patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis. Am. J. Respir. Cell Mol. Biol. 21: 693-700.
42. Scotton, C. J., and R. C. Chambers. 2007. Molecular targets in pulmonary fibrosis: the myofibroblast in focus. Chest 132: 1311-1321. (Pubitemid 47621009)
43. Shi-Wen, X., Y. Chen, C. P. Denton, M. Eastwood, E. A. Renzoni, G. Bou-Gharios, J. D. Pearson, M. Dashwood, R. M. du Bois, C. M. Black, et al. 2004. Endothelin-1 promotes myofibroblast induction through the ETA receptor via a rac/phosphoinositide 3-kinase/Akt-dependent pathway and is essential for the enhanced contractile phenotype of fibrotic fibroblasts. Mol. Biol. Cell 15: 2707-2719.
44. Valdenaire, O., E. Rohrbacher, and M. G. Mattei. 1995. Organization of the gene encoding the human endothelin-converting enzyme (ECE-1). J. Biol. Chem. 270: 29794-29798.
45. Massai, L., N. Volpi, P. Carbotti, M. Fruschelli, M. Mencarelli, A. Pecorelli, M. Muscettola, M. Aglianò, C. Alessandrini, and G. Grasso. 2007. Endothelin-1 and endothelin-converting enzyme-1 in human granulomatous pathology of eyelid: an immunohistochemical and in situ hybridization study in chalazia. Histol. Histopathol. 22: 1343-1354.